NVO
Novo Nordisk A/S
38.60$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 47.4% | 44.4% | 38.9% | 48.1% | 49.1% | 34.5% | 35.7% | 33.7% | 35.5% | 31.8% | 31.7% | 35.1% | |
| 10.0% | 4.6% | 2.1% | 14.3% | 14.3% | 3.4% | 8.0% | 3.8% | 6.3% | 4.9% | 3.8% | 7.5% | |
| 15.9% | 9.6% | 3.1% | 17.0% | 18.8% | 5.6% | 8.5% | 3.9% | 6.4% | 5.0% | 3.9% | 7.6% | |
| 18.0% | 23.9% | 24.0% | 18.0% | 17.5% | 18.8% | 17.7% | 17.8% | 18.0% | 13.9% | 17.9% | 18.2% | |
| 9.8% | 10.1% | 11.2% | 9.8% | 9.5% | 8.8% | 8.8% | 9.5% | 9.3% | 9.1% | 9.2% | 8.6% | |
| 191.2% | – | – | – | 30.2% | 34.9% | 35.2% | 37.5% | 37.7% | 38.4% | – | – | |
| – | 1.4% | – | – | – | 4.3% | – | – | – | 3.7% | 3.6% | 3.3% | |
| 18.6% | 17.8% | 20.0% | 15.0% | 13.7% | 19.5% | 22.4% | 22.4% | 20.8% | 20.3% | 19.7% | 17.2% | |
| 69.0% | 66.1% | 66.9% | 69.5% | 69.7% | 69.2% | 71.7% | 65.1% | 66.8% | 64.3% | 63.7% | 62.8% | |
| 57.5% | 53.9% | 55.4% | 50.9% | 52.4% | 46.7% | 48.3% | 43.0% | 45.7% | 39.7% | 40.3% | 40.2% | |
| 2.2% | 2.1% | 3.4% | 1.5% | 1.4% | 2.8% | 4.6% | 2.5% | 2.3% | 2.2% | 4.9% | 3.1% | |
| 6.7% | 8.1% | 4.4% | 8.1% | 6.1% | 6.2% | 4.0% | 5.9% | 4.7% | 3.6% | 24.0% | 26.0% | |
| 46.8% | 5.1% | 5.6% | 97.2% | 12.9% | 18.1% | 19.7% | 18.1% | 17.4% | 21.9% | 21.3% | 20.5% | |
| 31.0% | 33.9% | 33.1% | 30.5% | 30.3% | 30.8% | 28.3% | 34.9% | 33.2% | 35.7% | 36.3% | 37.2% | |
| 30.6% | 33.3% | 33.1% | 30.4% | 30.6% | 31.0% | 28.1% | 34.1% | 32.9% | 36.0% | 36.9% | 37.7% | |
| 10.5% | 1.4% | 1.5% | 8.4% | 1.1% | 1.0% | 0.9% | 0.9% | 0.9% | 0.8% | 0.8% | 0.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.